Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Confocal Laser Endomicroscopy in a Critically Ill COVID-19 Patient

  • Danilevskaya, Olesya (Department of Endoscopy, FSBI Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russia) ;
  • Sazonov, Dmitry (Department of Endoscopy, FSBI Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russia) ;
  • Klypa, Tatyana (Intensive Care Unit, FSBI Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russia) ;
  • Zabozlaev, Fedor (Department of Pathology, FSBI Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russia) ;
  • Popova, Elena (Laboratory of Clinical Pulmonology, FSBI Pulmonology Scientific Research Institute under Federal Medical Biological Agency of Russia)
  • Received : 2022.03.01
  • Accepted : 2022.03.22
  • Published : 2022.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

We thank professor Alexander Averyanov, Evgeny Ilyushnikov, Dmitry Panchenkov and Bychinin Mikhail for their help in organizing of the study.

References

  1. Thiberville L, Salaun M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C, et al. Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J 2009;33:974-85. https://doi.org/10.1183/09031936.00083708
  2. Salaun M, Roussel F, Hauss PA, Lachkar S, Thiberville L. In vivo imaging of pulmonary alveolar proteinosis using confocal endomicroscopy. Eur Respir J 2010;36:451-3. https://doi.org/10.1183/09031936.00194509
  3. Lesur O, Chagnon F, Lebel R, Lepage M. In vivo endomicroscopy of lung injury and repair in ARDS: potential added value to current imaging. J Clin Med 2019;8:1197. https://doi.org/10.3390/jcm8081197
  4. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020;46:586-90. https://doi.org/10.1007/s00134-020-05985-9
  5. Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M, et al. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury. Respir Physiol Neurobiol 2021;288:103645. https://doi.org/10.1016/j.resp.2021.103645
  6. Heching M, Lev S, Shitenberg D, Dicker D, Kramer MR. Surfactant for the treatment of ARDS in a patient with COVID-19. Chest 2021;160:e9-12. https://doi.org/10.1016/j.chest.2021.01.028
  7. Busani S, Dall'Ara L, Tonelli R, Clini E, Munari E, Venturelli S, et al. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. Ther Adv Respir Dis 2020;14:1753466620951043.